Patents Assigned to BioMirna Holdings Ltd.
  • Patent number: 9926603
    Abstract: A procedure and an apparatus are described for identifying individuals at risk of pulmonary tumour and/or for diagnosing a pulmonary tumour using the study of levels of expression of miRNA in the blood or another biological fluid. Also described are a method and a compound for reducing or eliminating a risk of pulmonary tumour by rebalancing the miRNAs that are underexpressed or overexpressed.
    Type: Grant
    Filed: June 20, 2014
    Date of Patent: March 27, 2018
    Assignee: Biomirna Holdings Ltd.
    Inventors: Gabriella Sozzi, Ugo Pastorino, Mattia Boeri
  • Publication number: 20120225925
    Abstract: A procedure and an apparatus are described for identifying individuals at risk of pulmonary tumour and/or for diagnosing a pulmonary tumour using the study of levels of expression of miRNA in the blood or another biological fluid. Also described are a method and a compound for reducing or eliminating a risk of pulmonary tumour by rebalancing the miRNAs that are underexpressed or overexpressed.
    Type: Application
    Filed: February 7, 2012
    Publication date: September 6, 2012
    Applicant: BioMirna Holdings Ltd.
    Inventors: Gabriella Sozzi, Ugo Pastorino, Mattia Boeri